# Immunome, Inc. (IMNM): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/imnm for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targete...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $17.89 USD |
| Market Cap | $2.11B |
| P/E (TTM) | — |
| EPS (TTM) | −$2.53 |
| 52-Week Range | $14.64 – $30.06 |
| Dividend Yield (TTM) | — |

## Dividend

IMNM has no dividend payment history in our records.

## Frequently Asked Questions

### What does Immunome, Inc. do?

Immunome, Inc. (IMNM) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is IMNM's market cap?

Immunome, Inc. (IMNM) has a market capitalization of approximately $2.11 billion, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does IMNM pay a dividend?

No, Immunome, Inc. (IMNM) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is IMNM profitable?

Immunome, Inc. (IMNM) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has IMNM ever paid a dividend?

No. Dividend Data's records show no dividend payments from Immunome, Inc. (IMNM). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/imnm
- Dividend history & safety: https://www.dividenddata.com/stocks/imnm/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/imnm/earnings
- Financial statements: https://www.dividenddata.com/stocks/imnm/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/imnm/valuation
- Peer comparison: https://www.dividenddata.com/stocks/imnm/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.